TANGO With SCN1A: Can This Molecular Dance Defeat Dravet Syndrome?

Comment

Jacy L Wagnon. Epilepsy Curr. 2020.

. 2020 Dec 4;21(1):60-61.

doi: 10.1177/1535759720975750. eCollection 2021 Jan-Feb.

No abstract available

Comment on

Antisense oligonucleotides increase Scn1a expression and reduce seizures and SUDEP incidence in a mouse model of Dravet syndrome.
Han Z, Chen C, Christiansen A, Ji S, Lin Q, Anumonwo C, Liu C, Leiser SC, Meena, Aznarez I, Liau G, Isom LL. Han Z, et al. Sci Transl Med. 2020 Aug 26;12(558):eaaz6100. doi: 10.1126/scitranslmed.aaz6100. Sci Transl Med. 2020. PMID: 32848094

1. Han Z, Chen C, Christiansen A, et al. Antisense oligonucleotides increase Scn1a expression and reduce seizures and SUDEP incidence in a mouse model of Dravet syndrome. Sci Transl Med. 2020;12(558):eaaz6100 doi:10.1126/scitranslmed.aaz6100 - PubMed
1. Oh Y, Waxman SG. Novel splice variants of the voltage-sensitive sodium channel alpha subunit. Neuroreport. 1998;9(7):1267–1272. - PubMed
1. Carvill G, Engel K, Ramamurthy A, et al. Aberrant inclusion of a poison exon causes Dravet syndrome and related SCN1A-associated genetic epilepsies. Am J Hum Genet. 2018;103(6):1022–1029. - PMC - PubMed
1. Lim KH, Han Z, Jeon HY, et al. Antisense oligonucleotide modulation of non-productive alternative splicing upregulates gene expression. Nat Commun. 2020;11(1):3501. - PMC - PubMed
1. Lenk GM, Jafar-Nejad P, Hill SF, et al. Scn8a antisense oligonucleotide is protective in mouse models of SCN8A encephalopathy and Dravet syndrome. Ann Neurol. 2020;87(3):339–346. - PMC - PubMed